Number of the records: 1
KATP kanály
SYS d054086 LBL 00000cz--a2200000n--4500 005 20250606214835.8 008 080101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 065 $a D12.776.157.530.400.600.450.550 065 $a D12.776.543.550.450.750.450.550 065 $a D12.776.543.585.400.750.450.550 066 $a 01 $c 03 150 $a KATP kanály $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo 450 $w v $a ATP-Sensitive Potassium Channel $2 eng 450 $w v $a ATP-Sensitive Potassium Channels $2 eng 450 $w v $a KATP Channel $2 eng 450 $w v $a ATP senzitívny draslíkový kanál $2 slo 450 $w v $a ATP-senzitívne draslíkové kanály $2 slo 450 $w v $a KATP kanál $2 slo 550 $7 sllk_us_auth*d046768 $Y Nesidioblastosis $w b $a nezidioblastóza 550 $7 sllk_us_auth*d026902 $Y Potassium Channel Blockers $w p $a blokátory draslíkových kanálov 665 $a 2008 $2 eng 665 $a Potassium Channels, Inwardly Rectifying (1991-2007) $2 eng 680 9-
$i Heteromultimers of Kir6 channels (the pore portion) and sulfonylurea receptor (the regulatory portion) which affect function of the HEART; PANCREATIC BETA CELLS; and KIDNEY COLLECTING DUCTS. KATP channel blockers include GLIBENCLAMIDE and mitiglinide whereas openers include CROMAKALIM and minoxidil sulfate. $2 eng 750 -2
$a KATP Channels $2 eng 980 $x M
Number of the records: 1